Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982 May;13(5):661–664. doi: 10.1111/j.1365-2125.1982.tb01433.x

Clindamycin passage into human milk.

B Stéen, A Rane
PMCID: PMC1402074  PMID: 7082533

Abstract

1 The clindamycin bioactivity was measured during the dosage interval in the plasma of women with puerperal infections and in their breast milk. 2 There was a marked interindividual variation in the peak levels. The clindamycin bioactivity in the milk ranged from 1/10 to several times the corresponding bioactivity in the plasma that was collected at the same time. 3 The concentration of clindamycin in the milk (bioactivity) at the end of the dosage interval correlated with the area under the plasma concentration v time curve. 4 Clindamycin is thus transferred into human breast milk. Although the actual amounts secreted are small, the wellknown side effects and the lack of knowledge about the disposition and effects of clindamycin in newborn infants are strong arguments against nursing during treatment with this drug.

Full text

PDF
661

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gordon R. C., Regamey C., Kirby W. M. Serum protein binding of erythromycin, lincomycin, and clindamycin. J Pharm Sci. 1973 Jul;62(7):1074–1077. doi: 10.1002/jps.2600620704. [DOI] [PubMed] [Google Scholar]
  2. KNOWLES J. A. EXCRETION OF DRUGS IN MILK--A REVIEW. J Pediatr. 1965 Jun;66:1068–1082. doi: 10.1016/s0022-3476(65)80094-4. [DOI] [PubMed] [Google Scholar]
  3. Kampmann J. P., Johansen K., Hansen J. M., Helweg J. Propylthiouracil in human milk. Revision of a dogma. Lancet. 1980 Apr 5;1(8171):736–737. doi: 10.1016/s0140-6736(80)91233-7. [DOI] [PubMed] [Google Scholar]
  4. Rane A., Tunell R. Ethosuximide in human milk and in plasma of a mother and her nursed infant. Br J Clin Pharmacol. 1981 Dec;12(6):855–858. doi: 10.1111/j.1365-2125.1981.tb01320.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Roberts A. P., Eastwood J. B., Gower P. E., Fenton C. M., Curtis J. R. Serum and plasma concentrations of clindamycin following a single intramuscular injection of clindamycin phosphate in maintenance haemodialysis patients and normal subjects. Eur J Clin Pharmacol. 1978 Dec 18;14(6):435–439. doi: 10.1007/BF00716386. [DOI] [PubMed] [Google Scholar]
  6. Stec G. P., Greenberger P., Ruo T. I., Henthorn T., Morita Y., Atkinson A. J., Jr, Patterson R. Kinetics of theophylline transfer to breast milk. Clin Pharmacol Ther. 1980 Sep;28(3):404–408. doi: 10.1038/clpt.1980.180. [DOI] [PubMed] [Google Scholar]
  7. Wagner J. G., Novak E., Patel N. C., Chidester C. G., Lummis W. L. Absorption, excretion and half-life of clinimycin in normal adult males. Am J Med Sci. 1968 Jul;256(1):25–37. doi: 10.1097/00000441-196807000-00004. [DOI] [PubMed] [Google Scholar]
  8. Wilson J. T., Brown R. D., Cherek D. R., Dailey J. W., Hilman B., Jobe P. C., Manno B. R., Manno J. E., Redetzki H. M., Stewart J. J. Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences. Clin Pharmacokinet. 1980 Jan-Feb;5(1):1–66. doi: 10.2165/00003088-198005010-00001. [DOI] [PubMed] [Google Scholar]
  9. Yurchak A. M., Jusko W. J. Theophylline secretion into breast milk. Pediatrics. 1976 Apr;57(4):518–520. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES